Thermo Fisher Scientific Adds Digital PCR to Genetic Analysis Capabilities

Go back to Thermo Fisher Scientific Adds Digital PCR to Genetic Analysis Capabilities

Thermo Fisher Scientific (TMO) PT Raised to $650 at Benchmark

September 22, 2021 7:26 AM EDT

Benchmark analyst Robert Wasserman raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $650.00 (from $580.00) while maintaining a Hold rating.

The analyst commented, "Thermo Fisher held an analyst day last week and provided very positive initial financial guidance for full year 2022, including 8%... More